Eisai announced on September 25 that the intravenous drug Leqembi has been approved in Japan for the treatment of Alzheimer's disease.
Eisai Announces Japanese Approval of Leqembi for Alzheimer's Disease Treatment
Sep 25, 2023 13:23
CST Updated
13:23
Eisai
Pharmaceutical Product R&D and Manufacturer